イベント

すべて表示
    Join BIOCYTOGEN at CADA Annual Scientific Symposium

    Join BIOCYTOGEN at CADA Annual Scientific Symposium

    June 17, 2025
    〜でシェア:

    Biocytogen is excited to announce our sponsorship and participation in the CADA 2025 Annual Scientific Symposium from June 17–20, 2025, in Chicago, Illinois. This is a unique opportunity to join us and explore the latest research in biopharmaceutical innovations for diabetes and metabolic diseases. Come connect with leaders from global pharmaceutical companies and engage with active members of the community from around the world!

     

    What is CADA Annual Scientific Symposium?

    The CADA Annual Scientific Symposium is organized by the Chinese American Diabetes Association (CADA), a nonprofit organization based in the United States that is committed to advancing scientific research aimed at curing diabetes and related metabolic diseases. At the annual meeting, participants will present and discuss abstracts of the most recent research submitted by scientists and professionals from around the globe.

     

    Event Overview

    Date: June 17, 2025 - June 20, 2025

    Venue: DoubleTree by Hilton Hotel Chicago - Magnificent Mile, 300 E Ohio St, Chicago, IL

    Event Schedule

    The CADA Annual Scientific Symposium will be a four day event. For more information please refer to 2025 CADA.

     

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

     

    We look forward to seeing you at the CADA Annual Scientific Symposium in Chicago,IL!